Crizanlizumab (Adakveo) failed to outperform placebo in patients with sickle cell disease, the phase III STAND trial showed.

NASHVILLE, Tenn. (WSMV) - Vanderbilt University Medical Center will lead a massive project aimed at discovering therapeutic antibodies through the use of Artificial Intelligence. Therapeutic ...

Share on Pinterest Scientists have found that an antibody treatment prevented a decline in muscle mass and bone density after using GLP-1 drugs. Rob and Julia Campbell/Stocksy Aging and limited ...

The potential of monoclonal antibodies (mAbs) as therapies is indisputable. The current mAbs market is expected to be around ~USD 150 billion. In 2021, five out of the top 10 selling drugs were ...

This event is now apart of the Neuroscience Virtual Event Series. Labroots' two-day international Laboratory Animal Science (LAS) virtual conference, that took place on February 3rd and 4th, 2016, is ...

What makes your blood different from someone else’s is your unique combination of protein molecules, called antigens and antibodies. Antigens live on the surface of your red blood cells.

* From the Critical Care Department (Dr. Dimopoulos), "Attikon" University Hospital, Athens, Greece; and Alfa Institute of Biomedical Sciences (Drs. Siempos, Korbila, Manta, and Falagas), Athens ...